Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborative group

Monique J. Roobol,Fritz H. Schröder,Jonas Hugosson,J. Stephen Jones,Michael W. Kattan,Eric A. Klein,Freddie C. Hamdy,David E. Neal,Jenny Donovan,Dipen J. Parekh,Donna P. Ankerst,G. Bartsch,Helmut Klocker,Wolfgang Horninger,Amine Benchikh,Gilles Salama,Arnauld Villers,Stephen J. Freedland,Daniel M. Moreira,Andrew J. Vickers,Hans Lilja,Ewout W. Steyerberg

Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborative group

2012

Objectives To compare the predictive performance and potential clinical usefulness of risk calculators of the European Randomized Study of Screening for Prostate Cancer (ERSPC RC) with and without information on prostate volume.

Keywords:

Prostate-specific antigen
Randomized controlled trial
Urology
Prostate biopsy
Prostate cancer
Prostate
Cohort study
Risk assessment
Medicine
Internal medicine
Oncology
collaborative group

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations